Document:

ex4-9.htm

    Exhibit
4.9

    

    

    Form
of Series A Common Stock Purchase Warrant

     

    Warrant
to Purchase Common Stock

     

    
      	Date of Issuance:
      October__, 2009	
              Warrant to Purchase
      an Aggregate of _____ shares
      of Common Stock

            

    

     

    FOR VALUE RECEIVED, Digital
Lifestyles Group, Inc., a Delaware corporation (the “Company”), promises to
issue in the name of, and sell and deliver to ________________ (the "Holder") a
certificate or certificates for an aggregate of _________ (______) shares of the
Company’s common stock, par value $0.03 per share (the “Common Stock”), upon
payment by the Holder of Thirty-one Cents ($0.31) per share (the “Exercise
Price”), with the Exercise Price being subject to adjustment in the
circumstances set forth below.

    

    
      	
               
      

            	
              1.

            	
              Exercise of
      Warrant.

            

    

    

    (A)           Exercise
Period.  The Holder may exercise this Warrant, in whole or in
part (but not as to fractional shares), at any time and time to time commencing
on the date hereof and ending at 5:00 p.m., Eastern Time, on the third (3rd)
anniversary of the date hereof (the “Exercise Period”).

    

    (B)           Exercise
Procedure.

    

    (i)           This
Warrant will be deemed to have been exercised at such time as the Company has
received all of the following items (the “Exercise Date”):

    

    (a)           a
completed Exercise Agreement, in the form attached hereto as Exhibit 1, executed
by the Holder (the “Purchaser”); and

    

    (b)           a
certified check or other immediately available funds payable to the Company in
an amount equal to the sum of the product of the Exercise Price multiplied by
the number of shares of Common Stock being purchased upon such
exercise.

    

    (ii)           Certificates
for the shares of Common Stock purchased upon exercise of this Warrant will be
delivered by the Company to the Purchaser within ten (10) business days after
the Exercise Date.  Unless this Warrant has expired or all of the
purchase rights represented hereby have been exercised, the Company will prepare
a new Warrant representing the rights formerly represented by this Warrant that
have not expired or been exercised.  The Company will, within such ten
(10) day period, deliver such new Warrant to the Holder at the address set forth
in this Warrant.

    

    (iii)           The
shares of Common Stock issuable upon the exercise of this Warrant will be deemed
to have been transferred to the Purchaser on the Exercise Date, and the
Purchaser will be deemed for all purposes to have become the record holder of
such Common Stock on the Exercise Date.

     

    
      
         

      

      
        1

        
          

        

      

      
         

      

    

    

    (iv)           The
issuance of certificates for shares of Common Stock upon the exercise of this
Warrant will be made without charge to the Purchaser for any issuance tax in
respect thereof or any other cost incurred by the Company in connection with
such exercise and related transfer of the shares; provided, however, that the
Company shall not be required to pay any tax that may be payable in respect of
any transfer involved in the issuance and delivery of any certificate or
instrument in a name other than that of the Holder of this Warrant, and that the
Company shall not be required to issue or deliver any such certificate or
instrument unless and until the person or persons requiring the issue thereof
shall have paid to the Company the amount of such tax or shall have established
to the satisfaction of the Company that such tax has been paid.

    

    (v)           The
shares of Common Stock issuable upon the exercise of this Warrant will be
“restricted securities” as that term is defined in the Securities Act of 1933.
The Company may insert the following or similar legend on the face of the
certificates evidencing shares of Common Stock if required in compliance with
state securities laws:

    

    "These securities have not been
registered under any state securities laws and may not be sold or otherwise
transferred or disposed of except pursuant to an effective registration
statement under any applicable state securities laws, or an opinion of counsel
satisfactory to counsel to the Company that an exemption from registration under
any applicable state securities laws is available."

    

    (C)           Fractional
Shares.  The Company shall not be required to issue fractions
of shares of Common Stock on the exercise of this Warrant.  The
Company shall not be obligated to issue any fractional share interests or
fractional warrant interests upon the exercise of this Warrant, nor shall it be
obligated to issue scrip or pay cash in lieu of fractional interests, provided,
however, that if a holder exercises all the Warrants held of record by such
holder, the Company shall at its option (i) eliminate the fractional interests
by rounding any fraction up to the nearest whole number of shares or (ii) within
30 days after the Exercise Date, deliver to the Purchaser a check payable to the
Purchaser, in lieu of such fractional share, in an amount equal to the value of
such fractional share as determined by the closing price of the Company’s Common
Stock as reported on the principal exchange on which the Company’s Common Stock
is then traded, as of the close of business on the Exercise Date.

    

    
      	
               
      

            	
              2.

            	
              Effect of
      Reorganization, Reclassification, Consolidation, Merger or
      Sale.

            

    

    

    (A)           Recapitalization or
Reclassification of Common Stock.  In case the Company shall at
any time prior to the Exercise of this Warrant or the expiration of the Exercise
Period, whichever first occurs, effect a recapitalization or reclassification of
such character that its Common Stock shall be changed into or become
exchangeable for a larger or smaller number of shares, then, upon the effective
date thereof, the number of shares of Common Stock that the Holder of this
Warrant shall be entitled to purchase upon exercise hereof shall be increased or
decreased, as the case may be, in direct proportion to the increase or decrease
in such number of shares of Common Stock by reason of such recapitalization or
reclassification, and the Exercise Price of such recapitalized or reclassified
Common Stock shall, in the case of an increase in the number of shares, be
proportionately decreased and, in the case of a decrease
in  the  number  of  shares,  be
proportionately increased.

     

    
      
         

      

      
        2

        
          

        

      

      
         

      

    

    

    (B)           Consolidation, Merger or
Sale. .  In case at any time prior to the exercise of this
Warrant or the expiration of the Exercise Period, whichever first occurs, the
Company should consolidate or merge with any other corporation (unless the
Company shall be the surviving entity) or transfer all or substantially all of
its assets to any other corporation preparatory to a dissolution (collectively,
the "Fundamental Transaction"), then the Company shall, as a condition precedent
to such transaction, provide notice to the Holder of not less than ten (10) of
days prior to the closing and/or effective date of such Fundamental Transaction
during which time the Holder shall have the right to exercise this Warrant
pursuant to its terms.  To the extent not exercised, this Warrant and
any right to acquire shares of the Company's Common Stock will automatically
expire on the closing date and/or effective date of such Fundamental
Transaction.

    

    (C)           Notice of
Adjustment.  Whenever the number of shares of Common Stock
purchasable upon exercise of this Warrant shall be adjusted as provided herein,
the Company shall file with its corporate records a certificate of its Chief
Financial Officer setting forth the computation and the adjusted number of
shares of Common Stock purchasable hereunder resulting from such adjustments,
and a copy of such certificate shall be mailed to the Holder.  Any
such certificate or letter shall be conclusive evidence as to the correctness of
the adjustment or adjustments referred to therein and shall be available for
inspection by the holders of the Warrants on any day during normal business
hours.

    

    3.           Reservation of Common
Stock.  The Company will at all time reserve and keep available
such number of shares of Common Stock as will be sufficient to permit the
exercise in full of this Warrant.  Upon exercise of this Warrant
pursuant to its terms, the Holder will acquire fully paid and non-assessable
ownership rights of the Common Stock, free and clear of any liens, claims or
encumbrances except as otherwise provided herein.

    

    4.           No Stockholder Rights or
Obligations.  This Warrant will not entitle the Holder hereof
to any voting rights or other rights as a stockholder of the
Company.  Until the shares of Common Stock issuable upon the exercise
of this Warrant are recorded as issued on the books and records of the Company’s
transfer agent, the Holder shall not be entitled to any voting rights or other
rights as a stockholder; provided, however, the Company uses its best efforts to
ensure that, upon receipt of the Exercise Agreement and payment of the Exercise
Price, the appropriate documentation necessary to effectuate the exercise of the
Warrant and the issuance of the Common Stock is accomplished as expeditiously as
possible.  No provision of this Warrant, in the absence of affirmative
action by the Holder to purchase Common Stock, and no enumeration in this
Warrant of the rights or privileges of the Holder, will give rise to any
obligation of such Holder for the Exercise Price or as a stockholder of the
Company.

     

    
      
         

      

      
        3

        
          

        

      

      
         

      

    

    

    5           Transferability.  Subject
to the terms hereof, this Warrant and all rights hereunder are transferable, in
whole or in part, upon surrender of this Warrant with a properly executed
Assignment in the form of Exhibit 2 hereto at the principal offices of the
Company.  This Warrant and the underlying shares of Common Stock may
not be offered, sold or transferred except in compliance with the Securities Act
of 1933, and any applicable state securities laws, and then only against receipt
of an agreement of the person to whom such offer or sale or transfer is made to
comply with the provisions of this Warrant with respect to any resale or other
disposition of such securities; provided that no such agreement shall be
required from any person purchasing this Warrant or the underlying shares of
Common Stock pursuant to a registration statement effective under the Securities
Act of 1933.  The Holder of this Warrant agrees that, prior to the
disposition of any security purchased on the exercise hereof other than pursuant
to a registration statement then effective under the Securities Act of 1933, or
any similar statute then in effect, the Holder shall give written notice to the
Company, expressing his intention as to such disposition.  Upon
receiving such notice, the Company shall present a copy thereof to its
securities counsel.  If, in the sole opinion of such counsel, which
such opinion shall not be unreasonably withheld, the proposed disposition does
not require registration of such security under the Securities Act of 1933, or
any similar statute then in effect, the Company shall, as promptly as
practicable, notify the Holder of such opinion, whereupon the Holder shall be
entitled to dispose of such security in accordance with the terms of the notice
delivered by the Holder to the Company.

    

    6.           Miscellaneous

    

    (A)           Notices.  Any
notices, requests or consents hereunder shall be deemed given, and any
instruments delivered, two days after they have been mailed by first class mail,
postage prepaid, or upon receipt if delivered personally or by facsimile
transmission, as follows:

    

    If to the
Company:                               Digital
Lifestyles Group, Inc.

    649 Sparta Highway

    Suite 102

    Crossville,
TN  38555

    Attention:  President

    

    If to the
Holder:                                    To
the address and/or facsimile of

    Holder as
recorded in the records

    of the
Company.

    

    except
that any of the foregoing may from time to time by written notice to the other
designate another address which shall thereupon become its effective address for
the purposes of this paragraph.

    

    (B)           Entire
Agreement.  This Warrant, including the exhibits and documents
referred to herein which are a part hereof, contain the entire understanding of
the parties hereto with respect to the subject matter and may be amended only by
a written instrument executed by the parties hereto or their successors or
assigns.  Any paragraph headings contained in this Warrant are for
reference purposes only and shall not affect in any way the meaning or
interpretation of this Warrant.

     

    
      
         

      

      
        4

        
          

        

      

      
         

      

    

    

    (C)           Governing Law. This
Warrants shall be construed in accordance with the laws of the State of
Delaware, without and application of the principles of conflicts of
laws.

    

    IN WITNESS WHEREOF, this
Warrant has been duly executed and the corporate seal affixed hereto, all as of
the day and year first above written.

     

    
      
        
          
            	 	 	 	Digital
      Lifestyles Group, Inc.	 
	 	 	 	 	 
	
                     

                  	 	 	
                    By:

                  	 
	
                     

                  	 	 	
                          
                      Ken
      Page, President and CEO

                    

                  	 

          

        

      

    

     

     

    5ex101.htm - Generated by SEC Publisher for SEC Filing

Exhibit 10.1

 

 

HepaLife Technologies, Inc.

60 State Street, Suite 700

Boston, MA  02109

October 13, 2009

 

Mr. Amit S. Dang

2000 Town Center, Suite 1900

Southfield, MI 48075

 

Re: Contract Interim Executive-Services Agreement

 

Dear Mr. Dang: 

 

This letter sets forth the terms and conditions of your Contract Interim Executive-Services Agreement (the “Agreement”) with HepaLife Technologies, Inc. (the “Company").

 

                1. Duties. Under terms of the Agreement, you shall be contracted by the Company as its Interim President and Chief Executive Officer, or in any executive or non-executive position(s) as the Company, from time to time, may deem appropriate. In performance of your duties, you shall be subject to the direction of, and be reporting directly to, the Company's Board of Directors (the “Board”); provided that, if requested by the Board, you will immediately resign your position(s) of the Company. You shall be available to travel as the needs of the business require. You agree to devote such amount of your business time, energy and skill to the duties assigned to you by the Board as maybe reasonably necessary to fulfill your obligations hereunder. The Company acknowledges and understands that your services hereunder are provided on a part-time basis. 

 

2. Termination of Agreement. Anything herein to the contrary notwithstanding, the Company may terminate the Agreement at any time, with or without cause, and for any reason whatsoever, upon immediate written notice.  You may terminate the Agreement with or without cause, and for any reason whatsoever, upon written notice of no fewer than 90 days; your notice to the Company may be waived upon mutual consent of the Company.  In the event of termination by either party, with or without cause: (i) you shall not be entitled to any form of contract cancellation fees, non-performance fees, or monthly fees; (ii) you shall no longer be eligible for reimbursement of expenses not previously approved or within the terms of the Agreement under Paragraph 5; (iii) any and all unexercised Options, whether vested or not, shall expire and shall no longer be exercisable as of the date of termination of the Agreement, except under the conditions detailed in Paragraph 4(b); (iv) you will not be entitled to any financial compensation beyond the terms provided for in the Agreement, and (v) neither party hereto shall have any further rights or obligations hereunder, except obligations expressly stated to survive the termination of the Agreement.  Nothing shall limit your right to be indemnified by the Company, subject to its indemnification policies then in effect, and subject to the conditions detailed in Paragraph 3; for your actions as a director or officer of the Company, provided such indemnification would otherwise have been available to you.

 

3. Directors and Officers Insurance. During the term of the Agreement, the Company shall maintain Directors and Officers Insurance (the “D&O Insurance”) and (a) you shall be included as an “officer” of the Company under such policy and (b) you shall be provided reasonable and customary indemnification provisions as per the Company’s By-laws and Certificate of Incorporation that are at least as protective of you as the laws of the state in which the Company is then incorporated. The Company will use commercially reasonable efforts to maintain the D&O Insurance in effect for a period of not less than three years following the termination of this Agreement.

 

1

 

             4. Financial Terms. You shall be compensated by the Company for your services as follows: 

 

(a) Monthly Fee. Commencing October 13, 2009, you shall be paid a monthly fee of $7,000. You shall be responsible for withholding all applicable taxes. You will not be eligible for health benefits, vacation time, or other employee benefits.

 

(b) Stock Options. Within 30 days of execution of the Agreement, you and the Company shall have entered into a Stock Option Agreement (the “Stock Option Agreement”), pursuant to which you shall receive an (the “Option”) to purchase up to an aggregate of 100,000 shares of the Company’s common stock; the Option is subject to and shall have such restrictions, vesting requirements and exercise provisions as are set forth in the Stock Option Agreement to be signed and executed by you and the Company. It is understood and agreed that the Option shall vest and become exercisable, subject to the terms of the Stock Option Agreement, only when: (a) With your support and contribution, the Company is able to successfully consummate a strategic transaction, or other such commercial transaction which the Board deems sufficiently substantial, or if (b) the Board, in its sole discretion, elects to accelerate the vesting of the Option.

 

                5. Expenses. You shall be entitled to reimbursement for reasonable travel and other out-of-pocket expenses necessarily incurred in the performance of your duties hereunder, upon submission and approval of written statements and bills in accordance with the then regular procedures of the Company. Expenses exceeding $500.00 for travel and $100 for meals and other incidentals must be approved in writing by the Company prior to your seeking reimbursement for the same.

 

               6. Your Representations and Warranties. You represent and warrant to the Company that (a) you are under no contractual or other restriction or obligation which is inconsistent with the execution of the Agree­ment, the performance of your duties hereunder, or the other rights of the Company hereunder, and (b) you are under no physical or mental disability that would hinder your performance of duties under this Agreement, and (c) you are not party to any ongoing civil or criminal proceedings, and have not been party such proceedings within the past five years, and do not know of any such proceeding that may be threatened or pending against you, and (d) you are not currently engaged in activities and will not knowingly engage in future activities that may cause embarrassment to the Company or tarnish the reputation or public image of the Company, including but not necessarily limited to association with or party to: any criminal behavior(s) such as drug use, theft, or any other potential or active violation of law; political controversy, civil disobedience, or public protest; lewd, lascivious behavior.

 

7. Non Competition; Non Solicitation.  (a)   In view of the unique and valuable services it is expected that you will render to the Company, your knowledge of its trade secrets, and other proprietary information relating to the business of the Company and in consideration of the compensation to be received hereunder, you will not, during the term of this Agreement, engage in, or otherwise directly or indirectly, be employed by, or act as a consultant or lender to, or, without the prior written approval of the Board, be a director, officer, owner, or partner of, any other business or organization that is engaged in the same field of research and development as is the Company. Nothing herein shall be deemed to preclude you from being an officer, director, owner, investor in, or partner of, any business or organization which is not competing with the Company, provided the same does not in any manner whatsoever impair your ability to perform your duties under the Agreement.

 

                                (b) During the term of the Agreement, and for a period of one year following termination of the Agreement, you will not directly or indirectly reveal the name of, solicit or interfere with, or endeavor to entice away from the Company any of its suppliers, customers, or employees.

 

                                (c) During the term of the Agreement and thereafter following the termination of the Agreement, you shall not make any critical or disparaging statements about the Company or any of its employees, directors or products to any other person or entity.

 

                                (d) Since a breach of the provisions of this Paragraph 7 could not adequately be compensated by money damages, the Company shall be entitled, in addition to any other right and remedy available to it, to an injunction restraining such breach or a threatened breach, and in either case no bond or other security shall be required in connection therewith, and you hereby consent to the issuance of such injunction. You agree that the provi­sions of this Paragraph 7 are necessary and reasonable to protect the Company in the conduct of its business. If any restriction contained in this Paragraph 7 shall be deemed to be invalid, illegal, or unenforceable by reason of the extent, duration, or geographical scope thereof, or  

2

 

otherwise, then the court making such determination shall have the right to reduce such extent, duration, geographical scope, or other provisions hereof, and in its reduced form such restriction shall then be enforceable in the manner contemplated hereby. This Paragraph 7 shall survive the termination of the Agreement.

 

                8. Intellectual Property. Any interest in patents, patent applications, inventions, copyrights, developments, and processes (“Intellectual Property”) which you now, or hereafter during the period for which this Agreement is in effect, may own or develop relating to the fields in which the Company may then be engaged shall belong to the Company; and forthwith upon request of the Company, you shall execute all such assignments and other documents and take all such other action as the Company may reasonably request in order to vest in the Company all your right, title, and interest in and to such Intellectual Property free and clear of all liens, charges, and encumbrances. This Paragraph 8 shall survive the termination of the Agreement.

 

                9. Confidential Information. All confidential information which you may now possess, or may obtain or create prior to the such time as the Agreement is terminated, relating to the business of the Company, or any customer or supplier of the Company, or any agreements, arrangements, or understandings to which the Company is a party, shall not be disclosed or made accessible by you to any other person or entity either during or after the termination the Agreement or used by you except during the term of the Agreement in the business and for the benefit of the Company. You shall return all tangible evidence of such confidential information to the Company prior to or at the termination of the Agreement. This Paragraph 9 shall survive the termination of the Agreement.

10. Successors and Assigns. This Agreement shall inure to the benefit of and be binding upon the Company and its successors and assigns. In view of the personal nature of the services to be performed under this Agreement by you, you shall not have the right to assign or transfer any of your rights, obligations or benefits under this Agreement, except as otherwise noted herein.

11. No Reliance on Representations. You acknowledge that you are not relying, and have not relied, on any promise, representation or statement made by or on behalf of the Company which is not set forth in this Agreement. 

12. Entire Agreements; Amendments. This Agreement sets forth the entire understanding for the parties with respect to the terms of the Agreement, supersedes all existing agreements between you and the Company concerning matters in the Agreement, and may be modified only by a written instrument duly executed by each of you and Company. 

                13. Waiver. Any waiver by either party of a breach of any provision of this Agreement shall not operate as or be construed to be a waiver of any other breach of such provision or of any breach of any other provision of this Agreement. The failure of a party to insist upon strict adherence to any term of this Agreement on one or more occasions shall not be considered a waiver or deprive that party of the right thereafter to insist upon strict adherence to that term or any other term of this Agreement. Any waiver must be in writing.

 

                14. Construction. You and the Company have participated jointly in the negotiation and drafting of this Agreement. In the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by you and the Company and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any of the provisions of this Agreement. Any reference to any federal, state, local, or foreign statute or law shall be deemed also to refer to all rules and regulations promulgated thereunder, unless the context requires otherwise. The word “including” shall mean including without limitation. The headings in this Agreement are solely for the convenience of reference and shall be given no effect in the construction or interpretation of this Agreement.

 

                15. Severability. Any term or provision of this Agreement that is invalid or unenforceable in any situation in any jurisdiction shall not affect the validity or enforceability of the remaining terms and provisions hereof or the validity or enforceability of the offending term or provision in any other situation or in any other jurisdiction.

 

                16. Notices. All notices, demands or requests made pursuant to, under or by virtue of this Agreement must be in writing and sent to the party to which the notice, demand or request is being made by (i) certified or registered mail, return receipt requested, (ii) nationally recognized overnight courier delivery, (iii) by facsimile transmission provided confirmation of transmission is mechanically or electronically  

3

 

generated and kept on file by the sending party or (iv) hand delivery as follows:

 

                                To the Company:

 

HepaLife Technologies, Inc.

Attention: Mr. Joseph Sierchio, Director

110 East 59th Street, 29th Floor

New York, NY  10022

 

                                To you:

 

Mr. Amit S. Dang

2000 Town Center, Suite 1900

Southfield, MI 48075

 

or to such other address, facsimile number, or email address, as is specified by a party by notice to the other party given in accordance with the provisions of this Paragraph 15. Any notice given in accordance with the provisions of this Paragraph 16 shall be deemed given (i) three (3) Business Days after mailing (if sent by certified mail), (ii) one (1) Business Day after deposit of same with a nationally recognized overnight courier service (if delivered by nationally recognized overnight courier service), or (iii) on the date delivery is made if delivered by hand or facsimile.

 

                17. Counterparts This Agreement may be executed in any number of counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.  

 

18. Governing Law. All other questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by the internal laws of the State of New York, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of New York or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, County of New York for the adjudication of any dispute hereunder or in connection herewith or therewith, or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof to such party at the address for such notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof.  Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law.  EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.

 

                19. Date of Agreement. The date of this Agreement shall be October 13, 2009 regardless of the date it is signed by you. 

 

If you find the foregoing acceptable, please acknowledge your acceptance of, and agreement with, the terms and conditions set forth above by signing the enclosed copy of this letter in the space provided and returning the same to the undersigned. 

Sincerely, 

 

HepaLife Technologies, Inc.

/s/ Javier Jimenez

Mr. Javier Jimenez

Director

4

 

On this 13th day of October, 2009, I agree to and accept the terms of the Agreement with HepaLife Technologies, Inc. on the terms and conditions set forth in this Agreement. 

Dated: October 13, 2009

 

/s/ Amit S. Dang

Mr. Amit S. Dang

 

 

5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00164-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00164-of-00352.parquet"}]]